Taysha gene therapies to release first quarter 2023 financial results and host conference call and webcast on may 11

Dallas, may 04, 2023 (globe newswire) -- taysha gene therapies, inc. (nasdaq: tsha), a clinical-stage gene therapy company focused on developing and commercializing aav-based gene therapies for the treatment of monogenic diseases of the central nervous system (cns), today announced that it will report its financial results for the first quarter ended march 31, 2023, and host a corporate update conference call and webcast on thursday, may 11, 2023, at 4:30 pm eastern time.
TSHA Ratings Summary
TSHA Quant Ranking